Greaves, Peter, Williams, Andrew, Eve, Malcolm (2004) First dose of potential new medicines to humans: How animals help. Nature Reviews Drug Discovery, 3 (3). pp. 226-236. ISSN 1474-1776. (doi:10.1038/nrd1329) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:11013)
The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided. | |
Official URL: http://dx.doi.org/10.1038/nrd1329 |
Abstract
The need for careful testing of new drugs in animal models before study in humans has been recognised by physicians since the First World War. Now, first human studies on new drugs are subject to detailed government guidelines, which in the European Union are presently being reinforced through the wide-ranging Clinical Trials Directive. However, despite their long history and widespread application, these guidelines are empirical and have been formulated with a paucity of critical scientific evidence. Here, we review the principles and the available, albeit limited, evidence that support the design and conduct of preclinical studies in a way that permits effective and safe first-dose studies of potential new medicines in humans.
Item Type: | Article |
---|---|
DOI/Identification number: | 10.1038/nrd1329 |
Additional information: | 51 NATURE PUBLISHING GROUP 780FY |
Subjects: | Q Science |
Divisions: | Divisions > Division of Natural Sciences > Physics and Astronomy |
Depositing User: | Maggie Francis |
Date Deposited: | 23 Sep 2008 17:47 UTC |
Last Modified: | 16 Nov 2021 09:49 UTC |
Resource URI: | https://kar.kent.ac.uk/id/eprint/11013 (The current URI for this page, for reference purposes) |
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):